Logo image of CX

CEMEX SAB-SPONS ADR PART CER (CX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CX - US1512908898 - ADR

12.525 USD
-0.04 (-0.36%)
Last: 1/15/2026, 10:54:04 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CX. CX was compared to 13 industry peers in the Construction Materials industry. While CX is still in line with the averages on profitability rating, there are concerns on its financial health. CX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year CX was profitable.
  • In the past year CX had a positive cash flow from operations.
  • CX had positive earnings in 4 of the past 5 years.
  • In the past 5 years CX always reported a positive cash flow from operatings.
CX Yearly Net Income VS EBIT VS OCF VS FCFCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

  • CX has a worse Return On Assets (4.70%) than 61.54% of its industry peers.
  • Looking at the Return On Equity, with a value of 10.03%, CX is in line with its industry, outperforming 46.15% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 5.31%, CX is doing worse than 69.23% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CX is below the industry average of 9.37%.
Industry RankSector Rank
ROA 4.7%
ROE 10.03%
ROIC 5.31%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
CX Yearly ROA, ROE, ROICCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

  • CX has a Profit Margin of 8.62%. This is in the lower half of the industry: CX underperforms 69.23% of its industry peers.
  • In the last couple of years the Profit Margin of CX has grown nicely.
  • With a Operating Margin value of 9.55%, CX is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
  • CX's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CX (32.75%) is better than 69.23% of its industry peers.
  • CX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.55%
PM (TTM) 8.62%
GM 32.75%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
CX Yearly Profit, Operating, Gross MarginsCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CX is destroying value.
  • Compared to 1 year ago, CX has an improved debt to assets ratio.
CX Yearly Shares OutstandingCX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CX Yearly Total Debt VS Total AssetsCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • CX has an Altman-Z score of 1.72. This is a bad value and indicates that CX is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CX (1.72) is worse than 61.54% of its industry peers.
  • CX has a debt to FCF ratio of 12.73. This is a negative value and a sign of low solvency as CX would need 12.73 years to pay back of all of its debts.
  • CX's Debt to FCF ratio of 12.73 is in line compared to the rest of the industry. CX outperforms 46.15% of its industry peers.
  • CX has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
  • CX has a better Debt to Equity ratio (0.44) than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 12.73
Altman-Z 1.72
ROIC/WACC0.36
WACC14.56%
CX Yearly LT Debt VS Equity VS FCFCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • CX has a Current Ratio of 0.91. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CX has a worse Current ratio (0.91) than 76.92% of its industry peers.
  • A Quick Ratio of 0.67 indicates that CX may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.67, CX is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.67
CX Yearly Current Assets VS Current LiabilitesCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

  • CX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -77.22%.
  • CX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 76.58% yearly.
  • Looking at the last year, CX shows a very negative growth in Revenue. The Revenue has decreased by -23.51% in the last year.
  • Measured over the past years, CX shows a small growth in Revenue. The Revenue has been growing by 4.29% on average per year.
EPS 1Y (TTM)-77.22%
EPS 3Y76.42%
EPS 5Y76.58%
EPS Q2Q%80%
Revenue 1Y (TTM)-23.51%
Revenue growth 3Y4.05%
Revenue growth 5Y4.29%
Sales Q2Q%3.81%

3.2 Future

  • Based on estimates for the next years, CX will show a very negative growth in Earnings Per Share. The EPS will decrease by -18.89% on average per year.
  • CX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.14% yearly.
EPS Next Y-37.74%
EPS Next 2Y-30.7%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue Next Year-5.27%
Revenue Next 2Y-0.21%
Revenue Next 3Y1.3%
Revenue Next 5Y4.14%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CX Yearly Revenue VS EstimatesCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
CX Yearly EPS VS EstimatesCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 -4

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.18, the valuation of CX can be described as reasonable.
  • Based on the Price/Earnings ratio, CX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • CX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.33.
  • The Price/Forward Earnings ratio is 4.50, which indicates a rather cheap valuation of CX.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CX indicates a rather cheap valuation: CX is cheaper than 100.00% of the companies listed in the same industry.
  • CX is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.18
Fwd PE 4.5
CX Price Earnings VS Forward Price EarningsCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CX is cheaper than 100.00% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CX indicates a somewhat cheap valuation: CX is cheaper than 69.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 34.07
EV/EBITDA 8.38
CX Per share dataCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • CX's earnings are expected to decrease with -18.89% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.13
EPS Next 2Y-30.7%
EPS Next 3Y-18.89%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 21.21%, CX is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.09, CX pays a better dividend. On top of this CX pays more dividend than 100.00% of the companies listed in the same industry.
  • CX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 21.21%

5.2 History

  • CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CX Yearly Dividends per shareCX Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • CX pays out 9.12% of its income as dividend. This is a sustainable payout ratio.
DP9.12%
EPS Next 2Y-30.7%
EPS Next 3Y-18.89%
CX Yearly Income VS Free CF VS DividendCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B
CX Dividend Payout.CX Dividend Payout, showing the Payout Ratio.CX Dividend Payout.PayoutRetained Earnings

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (1/15/2026, 10:54:04 AM)

12.525

-0.04 (-0.36%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)10-28
Earnings (Next)02-04
Inst Owners25.28%
Inst Owner Change-0.04%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.17B
Revenue(TTM)15.83B
Net Income(TTM)1.36B
Analysts78.67
Price Target11.85 (-5.39%)
Short Float %0.56%
Short Ratio0.97
Dividend
Industry RankSector Rank
Dividend Yield 21.21%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP9.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.04%
Min EPS beat(2)-51.46%
Max EPS beat(2)-12.62%
EPS beat(4)0
Avg EPS beat(4)-38.83%
Min EPS beat(4)-88.35%
Max EPS beat(4)-2.91%
EPS beat(8)1
Avg EPS beat(8)144.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.88%
Min Revenue beat(2)-6.15%
Max Revenue beat(2)-1.61%
Revenue beat(4)0
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-6.15%
Max Revenue beat(4)-1.61%
Revenue beat(8)0
Avg Revenue beat(8)-4.48%
Revenue beat(12)1
Avg Revenue beat(12)-3.51%
Revenue beat(16)2
Avg Revenue beat(16)1.69%
PT rev (1m)6.04%
PT rev (3m)28.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)100%
EPS NY rev (1m)0%
EPS NY rev (3m)16.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 10.18
Fwd PE 4.5
P/S 1.15
P/FCF 34.07
P/OCF 8.9
P/B 1.34
P/tB 4.52
EV/EBITDA 8.38
EPS(TTM)1.23
EY9.82%
EPS(NY)2.78
Fwd EY22.2%
FCF(TTM)0.37
FCFY2.94%
OCF(TTM)1.41
OCFY11.24%
SpS10.91
BVpS9.38
TBVpS2.77
PEG (NY)N/A
PEG (5Y)0.13
Graham Number16.11
Profitability
Industry RankSector Rank
ROA 4.7%
ROE 10.03%
ROCE 6.73%
ROIC 5.31%
ROICexc 5.67%
ROICexgc 10.4%
OM 9.55%
PM (TTM) 8.62%
GM 32.75%
FCFM 3.37%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
ROICexc(3y)7.18%
ROICexc(5y)6.61%
ROICexgc(3y)13.44%
ROICexgc(5y)12.5%
ROCE(3y)8.62%
ROCE(5y)7.97%
ROICexgc growth 3Y3.59%
ROICexgc growth 5Y8.98%
ROICexc growth 3Y3.55%
ROICexc growth 5Y10.09%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 12.73
Debt/EBITDA 2.16
Cap/Depr 117.98%
Cap/Sales 9.53%
Interest Coverage 250
Cash Conversion 73.17%
Profit Quality 39.1%
Current Ratio 0.91
Quick Ratio 0.67
Altman-Z 1.72
F-Score5
WACC14.56%
ROIC/WACC0.36
Cap/Depr(3y)98.23%
Cap/Depr(5y)87.02%
Cap/Sales(3y)7.21%
Cap/Sales(5y)6.61%
Profit Quality(3y)217.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.22%
EPS 3Y76.42%
EPS 5Y76.58%
EPS Q2Q%80%
EPS Next Y-37.74%
EPS Next 2Y-30.7%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-23.51%
Revenue growth 3Y4.05%
Revenue growth 5Y4.29%
Sales Q2Q%3.81%
Revenue Next Year-5.27%
Revenue Next 2Y-0.21%
Revenue Next 3Y1.3%
Revenue Next 5Y4.14%
EBIT growth 1Y-29.96%
EBIT growth 3Y2.07%
EBIT growth 5Y6.6%
EBIT Next Year60.32%
EBIT Next 3Y22.39%
EBIT Next 5YN/A
FCF growth 1Y-51.1%
FCF growth 3Y-11.58%
FCF growth 5Y-3.16%
OCF growth 1Y-17.47%
OCF growth 3Y0.91%
OCF growth 5Y6.96%

CEMEX SAB-SPONS ADR PART CER / CX FAQ

What is the ChartMill fundamental rating of CEMEX SAB-SPONS ADR PART CER (CX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CX.


What is the valuation status for CX stock?

ChartMill assigns a valuation rating of 6 / 10 to CEMEX SAB-SPONS ADR PART CER (CX). This can be considered as Fairly Valued.


What is the profitability of CX stock?

CEMEX SAB-SPONS ADR PART CER (CX) has a profitability rating of 4 / 10.


Can you provide the financial health for CX stock?

The financial health rating of CEMEX SAB-SPONS ADR PART CER (CX) is 2 / 10.


How sustainable is the dividend of CEMEX SAB-SPONS ADR PART CER (CX) stock?

The dividend rating of CEMEX SAB-SPONS ADR PART CER (CX) is 6 / 10 and the dividend payout ratio is 9.12%.